Sign Up Today and Learn More About DalCor Pharmaceuticals Stock
Invest in or calculate the value of your shares in DalCor Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
DalCor Pharmaceuticals Stock (DAPH)
DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
About DalCor Pharmaceuticals Stock
Founded
2015
Industries
Software, Artificial Intelligence, Data and Analytics
DalCor Pharmaceuticals Press Mentions
Stay in the know about the latest news on DalCor Pharmaceuticals
DalCor Pharmaceuticals Closes USD80M Series D Financing
finsmes • Mar 02, 2024
Q3 2023 marked a three-year low for venture deal volume in ...
betakit • Dec 19, 2023
DalCor Pharmaceuticals secures $80m in Series D financing
venturecapitaljournal • Sep 15, 2023
DalCor Pharmaceuticals announces Dal-GenE-2 confirmatory trial and closing of Series D financing round
morningstar • Sep 13, 2023
ACC: Merck anacetrapib reveal bodes neutral at best for DalCor’s dalcetrapib
fiercebiotech • Mar 20, 2019
DalCor Pharmaceuticals Management
Leadership team at DalCor Pharmaceuticals
Vice President Technical Operations
Peter Schuepbach
CFO
Michael Dixon
Join now and verify your accreditation status to gain access to:
- DalCor Pharmaceuticals current valuation
- DalCor Pharmaceuticals stock price
- Available deals in DalCor Pharmaceuticals and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading DalCor Pharmaceuticals Stock
How to invest in DalCor Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like DalCor Pharmaceuticals through EquityZen funds. These investments are made available by existing DalCor Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell DalCor Pharmaceuticals stock?
Shareholders can sell their DalCor Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
